SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019696
Filing Date
2021-08-13
Accepted
2021-08-13 16:01:50
Documents
78
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1508586
2 ex31-1.htm EX-31.1 19020
3 ex31-2.htm EX-31.2 18506
4 ex32-1.htm EX-32.1 7917
5 ex32-2.htm EX-32.2 7649
  Complete submission text file 0001493152-21-019696.txt   7697606

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE prph-20210630.xsd EX-101.SCH 52274
7 XBRL CALCULATION FILE prph-20210630_cal.xml EX-101.CAL 75790
8 XBRL DEFINITION FILE prph-20210630_def.xml EX-101.DEF 218597
9 XBRL LABEL FILE prph-20210630_lab.xml EX-101.LAB 445435
10 XBRL PRESENTATION FILE prph-20210630_pre.xml EX-101.PRE 340051
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1462267
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 211171993
SIC: 2834 Pharmaceutical Preparations